Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC

Overview of attention for article published in Advances in Therapy, January 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 4,445 followers.

RT @AdvancesTherapy: #openaccess article on the use of #panitumumab in combination with chemotherapy in patients with wild-type RAS metasta…

RT @AdvancesTherapy: #openaccess article on the use of #panitumumab in combination with chemotherapy in patients with wild-type RAS metasta…

RT @AdvancesTherapy: #openaccess article on the use of #panitumumab in combination with chemotherapy in patients with wild-type RAS metasta…

#openaccess article on the use of #panitumumab in combination with chemotherapy in patients with wild-type RAS metastatic colorectal cancer (#mCRC): https://t.co/4ubHDEeXxx https://t.co/yr8BFbveGM

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.